Press monitoring
Novo Nordisk files for regulatory approval of long-acting factor IX in the EU for the treatment of haemophilia B
7.1.2016 | Press monitoring
Bagsvaerd, Denmark, 7 January 2016 - Novo Nordisk today announced the submission to the European Medicines Agency of the Marketing Authorisation Application for the approval of long-acting factor IX, nonacog beta pegol. Nonacog beta pegol is a glycopegylated recombinant factor IX with a significantly improved pharmacokinetic (PK) profile,...
Emperra Digital Diabetes Care Closes Series B Round With Robert Bosch Venture Capital GmbH Joining as a New Investor
7.1.2016 | Press monitoring
Potsdam and Stuttgart, Germany, January 4, 2016 / B3C newswire / -- Emperra, a German start-up that has created a digital diabetes management solution consisting of smart hardware and software, has completed a Series B financing round of USD 3.1 million, with Robert Bosch Venture Capital GmbH (RBVC), a corporate venture capital company of the...
Novartis Pharmaceuticals collaborates with Qualcomm in digital innovation with the Breezhaler(TM) inhaler device to treat COPD
6.1.2016 | Press monitoring
Basel, January 5, 2016 - Novartis announced today a collaboration with Qualcomm Incorporated through its subsidiary, Qualcomm Life, Inc., in digital innovation with the Breezhaler(TM) inhaler device to treat COPD. Under this collaboration, Qualcomm Life will provide the technology solution for the connectivity of the next generation of the...
Scientists create nano-reactor for the production of hydrogen biofuel
6.1.2016 | Press monitoring
Scientists at Indiana University have created a highly efficient biomaterial that catalyzes the formation of hydrogen—one half of the "holy grail" of splitting H2O to make hydrogen and oxygen for fueling cheap and efficient cars that run on water. A modified enzyme that gains strength from being protected within the protein shell—or...
Merus and Gustave Roussy Form Strategic Collaboration to Develop Innovative Bispecific Antibodies for Therapeutic Immuno-Oncology Applications
4.1.2016 | Press monitoring
UTRECHT, The Netherlands and VILLEJUIF, France, Jan. 04, 2016 (GLOBE NEWSWIRE) -- Merus B.V., a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, and Institut Gustave Roussy, a leading Comprehensive Cancer Centre in Europe, today announced entry into a strategic collaboration to jointly develop...
Simple shell of plant virus sparks immune response against cancer
4.1.2016 | Press monitoring
The shells of a common plant virus, inhaled into a lung tumor or injected into ovarian, colon or breast tumors, not only triggered the immune system in mice to wipe out the tumors, but provided systemic protection against metastases, researchers from Case Western Reserve University and Dartmouth University report. The scientists tested a...
CRISPR treats genetic disorder in adult mammal
1.1.2016 | Press monitoring
Researchers have used CRISPR to treat an adult mouse model of Duchenne muscular dystrophy. This marks the first time that CRISPR has successfully treated a genetic disease inside a fully developed living mammal with a strategy that has the potential to be translated to human therapy. Researchers from Duke University had previously used CRISPR to...
ORNL cell-free protein synthesis is potential lifesaver
30.12.2015 | Press monitoring
Lives of soldiers and others injured in remote locations could be saved with a cell-free protein synthesis system developed at the Department of Energy's Oak Ridge National Laboratory. The device, a creation of a team led by Andrea Timm and Scott Retterer of the lab's Biosciences Division, uses microfabricated bioreactors to facilitate the...
A more durable protein hydrogel based on elastic silk-like protein
28.12.2015 | Press monitoring
Team of researchers examined the behavior of sea anemone to create a mechanically durable hydrogel. Since the body length and width of sea anemone varies almost ten-fold by shrinking rapidly and expanding slowly under stimulus, the team assumed that mechanically durable protein in its body could play an important role in contraction and...
Designer Cells Treat Psoriasis
25.12.2015 | Press monitoring
Psoriasis is a chronic skin condition that causes itchy, scaly lesions over parts of the body. Engineered “designer cells,” placed in microcapsules and implanted in mice, now offer hope for a psoriasis treatment that goes beyond daily pills and injections. “The cell recognizes the disease metabolite and coordinates a specific response,” said...
